Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:

Subscribers log in here

Diagnosis and treatment of diphtheria


Diphtheria is an infectious disease caused by the gram-positive bacillus Corynebacterium diphtheriae. Infection may lead to respiratory disease, cutaneous disease, or an asymptomatic carrier state. The word diphtheria comes from the Greek word for leather, which refers to the tough pharyngeal membrane that is the clinical hallmark of infection.

The diagnosis and treatment of diphtheria will be reviewed here. The epidemiology, pathophysiology, clinical manifestations, and prevention of this infection are discussed separately. (See "Epidemiology, pathophysiology and clinical manifestations of diphtheria" and "Standard immunizations for children and adolescents", section on 'Diphtheria, tetanus, and/or pertussis vaccines' and "Tetanus-diphtheria toxoid vaccination in adults".)


The diagnosis of diphtheria should be considered in the setting of relevant clinical manifestations (sore throat, malaise, cervical lymphadenopathy, and low grade fever) together with appropriate epidemiologic risk factors. Mild pharyngeal erythema typically progresses to areas of white exudate; these coalesce to form an adherent gray pseudomembrane that bleeds with scraping. Clinical suspicion for diphtheria should be further heightened in the setting of adherent pharyngeal, palatal, or nasal membranes, systemic toxicity, hoarseness, stridor, palatal paralysis, and/or serosanguineous nasal discharge [1]. (See "Epidemiology, pathophysiology and clinical manifestations of diphtheria", section on 'Clinical manifestations'.)

Definitive diagnosis of diphtheria requires culture of C. diphtheriae from respiratory tract secretions or cutaneous lesions, and a positive toxin assay. Routine laboratory results are usually non-specific and may include a moderately elevated white blood cell count and proteinuria.

Culture — Cultures should be obtained from the throat and nose including a portion of the membrane (if possible), and material from beneath the membrane [2]. Special culture media (Loffler's or Tindale's) are required; the microbiology laboratory should be notified of the suspected diagnosis so that the specimen is plated on appropriate media. Transport to the laboratory must be accomplished quickly since the media must be inoculated promptly [2].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Oct 15, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
  1. Farizo KM, Strebel PM, Chen RT, et al. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis 1993; 16:59.
  2. Clarridge JE, Popovic T, Inzana TJ. Diphtheria and other corynebacterial and coryneform infections. In: Topley and Wilson's Microbiology and Microbial Infections, Hausler WJ, Sussman M (Eds), Oxford University Press, New York City 1998. Vol 3, p.347.
  3. MacGregor RR. Corynebacterium diphtheriae. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2457.
  4. Efstratiou A, Engler KH, Mazurova IK, et al. Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis 2000; 181 Suppl 1:S138.
  5. Colman G, Weaver E, Efstratiou A. Screening tests for pathogenic corynebacteria. J Clin Pathol 1992; 45:46.
  6. Efstratiou A, Engler KH, Dawes CS, Sesardic D. Comparison of phenotypic and genotypic methods for detection of diphtheria toxin among isolates of pathogenic corynebacteria. J Clin Microbiol 1998; 36:3173.
  7. Komiya T, Shibata N, Ito M, et al. Retrospective diagnosis of diphtheria by detection of the Corynebacterium diphtheriae tox gene in a formaldehyde-fixed throat swab using PCR and sequencing analysis. J Clin Microbiol 2000; 38:2400.
  8. Engler KH, Efstratiou A. Rapid enzyme immunoassay for determination of toxigenicity among clinical isolates of corynebacteria. J Clin Microbiol 2000; 38:1385.
  9. Kovatch AL, Schuit KE, Michaels RH. Corynebacterium hemolyticum peritonsillar abscess mimicking diphtheria. JAMA 1983; 249:1757.
  10. Tiwari TS, Golaz A, Yu DT, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008; 46:395.
  11. American Academy of Pediatrics. Diphtheria. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012.
  13. American Academy of Pediatrics. Antibodies of animal origin (animal antisera). In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012.
  14. Kneen R, Pham NG, Solomon T, et al. Penicillin vs. erythromycin in the treatment of diphtheria. Clin Infect Dis 1998; 27:845.
  15. Zalma VM, Older JJ, Brooks GF. The Austin, Texas, diphtheria outbreak. Clinical and epidemiological aspects. JAMA 1970; 211:2125.
  16. McCloskey RV, Eller JJ, Green M, et al. The 1970 epidemic of diphtheria in San Antonio. Ann Intern Med 1971; 75:495.
  17. Miller LW, Bickham S, Jones WL, et al. Diphtheria carriers and the effect of erythromycin therapy. Antimicrob Agents Chemother 1974; 6:166.
  18. Zasada AA, Baczewska-Rej M, Wardak S. An increase in non-toxigenic Corynebacterium diphtheriae infections in Poland--molecular epidemiology and antimicrobial susceptibility of strains isolated from past outbreaks and those currently circulating in Poland. Int J Infect Dis 2010; 14:e907.
  19. Engler KH, Warner M, George RC. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae. J Antimicrob Chemother 2001; 47:27.
  20. Jayashree M, Shruthi N, Singhi S. Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatr 2006; 43:155.
  21. Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000; 181 Suppl 1:S110.